Clinical Trial Update: Neoadjuvant Immunotherapy and Chemotherapy Followed by Surgery in Unresectable Stage Ⅲ NSCLC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating neoadjuvant immunotherapy plus chemotherapy followed by surgery for unresectable stage III non-small cell lung cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN